SEC Form 4 · accession 0001547522-17-000058
COATES INTERNATIONAL LTD · COTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George J. Coates
Officer — President and CEO · Director · 10% Owner
Period of report
May 2, 2017
Accepted (ET)
May 4, 2017 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000948426
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred StockF2,F1 | $0.00 | May 2, 2017 | A | 900,000 | A | May 2, 2019 | — | Common Stock | 900,000,000 | 16,574,047 | D |
| Series B Convertible Preferred StockF4,F3 | $0.00 | May 2, 2017 | A | 900,000 | A | May 2, 2019 | — | Common Stock | 900,000,000 | 17,474,047 | D |
| Series B Convertible Preferred StockF6,F5 | $0.00 | May 2, 2017 | A | 900,000 | A | May 2, 2019 | — | Common Stock | 900,000,000 | 18,374,047 | D |
| Series B Convertible Preferred StockF8,F7 | $0.00 | May 2, 2017 | A | 709,590 | A | May 2, 2019 | — | Common Stock | 709,590,000 | 19,083,637 | D |
Explanation of responses
- F1There is no expiration date.
- F2Each share of Series B entitles the holder to 1,000 votes at any meeting where corporate matters are brought before the shareholders for a vote. The Series B is restricted, unregistered stock which is not convertible until the second annual anniversary after the date of issue, after which each share is freely convertible into 1,000 restricted, unregistered shares of common stock. In the event of a sale or change of control of the Corporation, the Series B shall become immediately convertible. The anti-dilution award of Series B Convertible Preferred Stock to Mr. Coates was determined to be the number of shares of Series B required to restore Mr. Coates' ownership percentage of outstanding common stock on a pro forma basis to 80.1%, assuming all of the Series B shares were converted into common stock.
- F3There is no expiration date.
- F4Each share of Series B entitles the holder to 1,000 votes at any meeting where corporate matters are brought before the shareholders for a vote. The Series B is restricted, unregistered stock which is not convertible until the second annual anniversary after the date of issue, after which each share is freely convertible into 1,000 restricted, unregistered shares of common stock. In the event of a sale or change of control of the Corporation, the Series B shall become immediately convertible. The anti-dilution award of Series B Convertible Preferred Stock to Mr. Coates was determined to be the number of shares of Series B required to restore Mr. Coates' ownership percentage of outstanding common stock on a pro forma basis to 80.1%, assuming all of the Series B shares were converted into common stock.
- F5There is no expiration date.
- F6Each share of Series B entitles the holder to 1,000 votes at any meeting where corporate matters are brought before the shareholders for a vote. The Series B is restricted, unregistered stock which is not convertible until the second annual anniversary after the date of issue, after which each share is freely convertible into 1,000 restricted, unregistered shares of common stock. In the event of a sale or change of control of the Corporation, the Series B shall become immediately convertible. The anti-dilution award of Series B Convertible Preferred Stock to Mr. Coates was determined to be the number of shares of Series B required to restore Mr. Coates' ownership percentage of outstanding common stock on a pro forma basis to 80.1%, assuming all of the Series B shares were converted into common stock.
- F7There is no expiration date.
- F8Each share of Series B entitles the holder to 1,000 votes at any meeting where corporate matters are brought before the shareholders for a vote. The Series B is restricted, unregistered stock which is not convertible until the second annual anniversary after the date of issue, after which each share is freely convertible into 1,000 restricted, unregistered shares of common stock. In the event of a sale or change of control of the Corporation, the Series B shall become immediately convertible. The anti-dilution award of Series B Convertible Preferred Stock to Mr. Coates was determined to be the number of shares of Series B required to restore Mr. Coates' ownership percentage of outstanding common stock on a pro forma basis to 80.1%, assuming all of the Series B shares were converted into common stock.